Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03458000 · ClinicalTrials.gov registry record · NA

Capsule Endoscopy for HEmorrhage in the ER

A NA study, sponsored by George Washington University.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT03458000: Completed NA study, sponsored by George Washington University.

NCT03458000 is a NA study that has completed, run by George Washington University. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03458000, a NA study, has completed, sponsored by George Washington University.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

This is a multi-center randomized controlled trial examining the use of Video Capsule Endoscopy (VCE) to discharge low-moderate risk patients with suspected upper gastrointestinal bleeds (UGIB) from the Emergency Department (ED.) The investigators will enroll 100 subjects at 4 sites who present with signs of hemodynamically stable UGIBs and compare VCE risk assessment to an Active Control (AC) group who receive inpatient upper endoscopy (EGD).

Primary Outcome

Our primary goal is to determine whether ED VCE is able to discharge low risk patients for outpatient management of upper GI bleeds.

Interventions

  • OTHER Standard of Care
  • DEVICE PillCam UGI

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2018-04-17
Est. Completion 2020-09-07
Phase NA
George Washington University

133 total trials

What the finished NCT03458000 record still lists

NCT03458000 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.

NCT03458000 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03458000 about?

NCT03458000 is a clinical study titled "Capsule Endoscopy for HEmorrhage in the ER". This is a multi-center randomized controlled trial examining the use of Video Capsule Endoscopy (VCE) to discharge low-moderate risk patients with suspected upper gastrointestinal bleeds (UGIB) from the Emergency Department (ED.) The investigators will enroll 100 subjects at 4 sites who present with...

What is the current status of trial NCT03458000?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-04-17. Estimated completion is 2020-09-07.

What interventions are being tested in trial NCT03458000?

The interventions under investigation include: Standard of Care (OTHER), PillCam UGI (DEVICE).

Who is sponsoring clinical trial NCT03458000?

This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03458000's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03458000, the US trial registry maintained by the National Library of Medicine. NCT03458000 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.